Articles tagged as

Food and Drug Administration

  1. Gilead's 3 Most Profitable Lines of Business (GILD)

  2. The Biggest Risks of Investing in Johnson & Johnson Stock (JNJ)

  3. The Biggest Risks of Investing in Celgene Stock (CELG)

  4. The Biggest Risks of Investing in Altria Stock (MO)

  5. The Top 5 Health Care Penny Stocks for 2016 (CRIS, GERN)

  6. The Top 5 Mid-Cap Biotechnology Stocks for 2016 (ALNY, ICPT)

  7. SBIO: ALPS Medical Breakthroughs ETF

  8. PPH: Market Vectors Pharmaceutical ETF

  9. The Biggest Risks of Investing in Pfizer Stock (PFE)

  10. How Will e-cigarettes Affect Big Tobacco? (RAI, PM)

  11. Celgene Vs. Gilead: Vetting for the Best Biopharma

  12. 10 Developments By Gilead Sciences That Could Boost Profits (GILD)

  13. How to Profit from the Generic Drug Trend

  14. How Does Biogen Make its Money?

  15. How NDAs Work and Why They're Important

  16. Could Amgen's Next Drug Be Worth $100 Billion?

  17. 3 Things That Could Hold Intuitive Surgical Back

  18. Did Orexigen Make A Big Mistake?

  19. Are These Biogen Idec's Next Blockbusters?

  20. Why Does Wall Street Hate MannKind?

  21. What’s The Drug That Will Finally Fight Obesity?

  22. Is Ariad On Track To Lose More Shares?

  23. What Is Amgen’s New Target?

  24. Will MannKind Finally Reach A Solid Ground?

  25. What Are The Real Economic Costs Of Obesity?

  26. Gilead Sciences: The New Market-Share Leader

  27. A Checklist For Successful Medical Technology Investment

  28. Getting Started In Stocks

  29. Top 4 Most Scandalous Insider Trading Debacles

  30. 8 Stages Of New Drug Development

  31. Investing In Medical Equipment Companies

  32. Using DCF In Biotech Valuation

  33. Investing In The Biotech Sector

  34. 4 Reasons Why You Love To Hate Big Businesses

  35. Evaluating Pharmaceutical Companies

  36. A Primer On The Biotech Sector

  37. Government Regulations: Do They Help Businesses?

  38. 7 Popular Diet Plans And What They Cost

  39. Baby Boomers Beware: Financial Fraud That Targets Seniors

  40. Scandals That Bring The CEOs Out

  41. Infamous Female Financiers

  42. A Year In Product Recalls

  43. Pharma Patent Trolls: Cheap Drugs At A Steep Price

  44. Investing In The Healthcare Sector

  45. Chasing Down Biotech Zombie Stocks

  46. The Ups And Downs Of Biotechnology

Trading Center